Neurocrine Biosciences Inc $4,199,262 Alkermes Plc $28,489,151 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375 Neurocrine Biosciences Inc $4,199,262 Alkermes Plc $28,489,151 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375